Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
GRAL vs WGS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
GRAL Captures Overall Composite Edge (54.5 HOLD vs 49.5 HOLD), While WGS Leads 5–1 on Growth & Valuation Pillars
GRAL Overall Winner
6-Pillar Tally: GRAL 1 – 5 WGS
Matrix Metrics: GRAL 7 – 3 WGS
As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over GeneDx Holdings Corp. (WGS) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while WGS wins 5–1 across the 6-pillar growth and valuation breakdown. GRAL trades at $105.60 (1.1x Forward P/E, -332.0% operating margin) versus WGS at $51.02 (40.6x Forward P/E, -13.7% operating margin).
- Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. WGS 49.5/100 HOLD) and 3.09β · 99% Vol risk profile, whereas WGS leads top-line expansion (+5.4% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: GRAL is currently in a Breakdown options structure phase (RSI 37.7); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About GRAL vs WGS
GRAL
Head-to-Head Winner
GRAIL, Inc. Common Stock
$105.60
-8.88% 1D
Market Cap
$5.2B
TTM Revenue
$167M
Forward P/E
1.1x
Beta / 30D Vol
3.09β · 99% Vol
Unified Composite Score
54.5
HOLD
Tech 35.0
Fund 49.0
Flow 57.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
WGS
GeneDx Holdings Corp. Class A Common Stock
$51.02
-2.58% 1D
Market Cap
$1.6B
TTM Revenue
$461M
Forward P/E
40.6x
Beta / 30D Vol
1.74β · 111% Vol
Unified Composite Score
49.5
HOLD
Tech 33.0
Fund 53.0
Flow 70.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (GRAL 1 – 5 WGS)
1. Valuation Multiples
GRAL
Forward P/E
1.1x
40.6x
Trailing P/E
1.1x
38.8x
PEG Ratio
N/M
N/M
EV / Revenue
31.6x
3.7x
2. Growth & Scale
WGS
Revenue Growth (YoY)
+3.7%
+5.4%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$167M
$461M
Market Cap
$5.2B
$1.6B
3. Profitability & Quality
WGS
Gross Margin
46.7%
68.8%
Operating Margin
-332.0%
-13.7%
Net Profit Margin
-243.8%
-24.1%
Return on Equity (ROE)
-17.3%
-41.4%
4. Balance Sheet & Cash Flow
WGS
Cash Generation (TTM)
-$312M
-$101M
Cash Flow Margin
N/A
-22.0%
Net Cash / Leverage
$57M Net Debt (0.03x D/E)
$119M Net Debt (0.88x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
WGS
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
93.0% (53rd %ile)
102.3% (21st %ile)
Put/Call OI Skew
0.81x (Call-Skewed)
7.82x (Put-Skewed)
OBV Trend / Tech Phase
DISTRIBUTION · Neutral
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
WGS
OpEx & R&D Intensity
N/A
82.5% of Rev ($380M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Diagnostics & Research Operator
Diagnostics & Research Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: GRAL (7) vs WGS (3)| Institutional Metric | GRAL | WGS | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $5.2B | $1.6B | GRAL | |
| Trailing P/E Ratio | 1.1x | 38.8x | GRAL | |
| Forward P/E Ratio | 1.1x | 40.6x | GRAL | |
| Revenue Growth (YoY) | +3.7% | +5.4% | WGS | |
| Operating Margin (TTM) | -332.0% | -13.7% | WGS | |
| Net Profit Margin | -243.8% | -24.1% | WGS | |
| Return on Equity (ROE) | -17.3% | -41.4% | GRAL | |
| 52-Week Range Position | 51% ($42–$166) | 14% ($32–$171) | GRAL | |
| Beta / 30D Volatility | 3.09β · 99% Vol | 1.74β · 111% Vol | GRAL | |
| Unified Institutional Score | 54.5 / 100 (HOLD) | 49.5 / 100 (HOLD) | GRAL | |
| Trailing 12M Revenue (USD) | $167M | $461M | Scale | |
| Gross Profit Margin (TTM) | 46.7% | 68.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 31.6x EV/Rev | N/M PEG · 3.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$312M ($57M Net Debt (0.03x D/E)) | -$101M ($119M Net Debt (0.88x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
GRAL +9.43 pp
3M Horizon
GRAL +85.03 pp
6M Horizon
GRAL +51.83 pp
1Y Horizon
GRAL +87.78 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GRAL Revenue | WGS Revenue | GRAL Op. Margin | WGS Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | N/A | $200M | N/A | -15.5% | WGS |
| FY2020 | N/A | $180M | N/A | -134.9% | WGS |
| FY2021 | N/A | $210M | N/A | -210.3% | WGS |
| FY2022 | N/A | $230M | N/A | -284.5% | WGS |
| FY2023 | $90M | $200M | -1627.6% | -89.2% | WGS |
| FY2024 | $130M | $310M | -1743.0% | -7.6% | WGS |
| FY2025 | $150M | $430M | -382.0% | -3.1% | WGS |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
GRAL
BREAKDOWN
Current IV
93.0%
IV Percentile
53rd %ile
Put/Call OI Skew
0.81x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
DISTRIBUTION
Exact GRAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
WGS
BREAKDOWN
Current IV
102.3%
IV Percentile
21st %ile
Put/Call OI Skew
7.82x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
GRAL Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
WGS Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
82.5% of Rev ($380M)
90D Engineering Disclosures
0 Published
Investor FAQ GRAL vs WGS Key Questions & Quantitative Answers
As of Nov 16, 2026, GRAIL, Inc. (GRAL) captures the overall head-to-head institutional edge over GeneDx Holdings Corp. (WGS) on higher Unified Composite conviction (54.5/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while WGS wins 5–1 across the 6-pillar growth and valuation breakdown. GRAL trades at $105.60 (1.1x Forward P/E, -332.0% operating margin) versus WGS at $51.02 (40.6x Forward P/E, -13.7% operating margin). Growth vs. Quality Trade-Off: GRAL earns the overall head-to-head edge with a stronger Unified Composite Score (54.5/100 HOLD vs. WGS 49.5/100 HOLD) and 3.09β · 99% Vol risk profile, whereas WGS leads top-line expansion (+5.4% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: GRAL is currently in a Breakdown options structure phase (RSI 37.7); meanwhile WGS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
WGS leads the Growth & Scale pillar: GRAL posts +3.7% YoY revenue growth and +0.0% YoY earnings growth on $167M TTM revenue (46.7% gross margin, -332.0% operating margin), compared with WGS at +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), GRAL cumulative revenue shifted +66.7% while WGS shifted +115.0%. In operating R&D and SG&A reinvestment, GRAL deploys N/A (0 90-day corporate R&D disclosures) versus 82.5% of Rev ($380M) (0 disclosures) for WGS.
GRAL screens cheaper on headline valuation multiples. GRAL trades at 1.1x Forward P/E, 1.1x Trailing P/E, N/M PEG, and 31.6x EV/Revenue (unreported FCF margin), whereas WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GRAL (-17.3% ROE) versus WGS (-41.4% ROE) capital efficiency.
In options market volatility and institutional positioning, GRAL carries 93.0% implied volatility (53rd %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.09β · 99% Vol realized risk). By comparison, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
WGS vs GRAL · Reverse Pair
GRAL vs RVMD
· Sector Peer
GRAL vs NTRA
· Sector Peer
GRAL vs GH
· Sector Peer
WGS vs SEZL
· Sector Peer
WGS vs NTRA
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem